Medicine for treating ischemic stroke and sequela thereof

Abstract

The invention relates to medicine for treating ischemic stroke and sequela thereof, which is the medicine prepared by taking Chinese herbal medicine as raw materials for treating ischemic stroke. The prior Chinese patent medicine and western medicine for treating ischemic stroke can only control or relieve the deterioration and the development of illness state, and have no ideal effect for the recovery of the illness and sequela. The medicine for treating ischemic stroke and sequela is characterized by being prepared from the following raw materials by weight: 230 to 250 portions of milk veteh, 15 to 17 portions of Chinese angelica, 15 to 17 portions of Szechuan Lovage Rhizome, 15 to 17 portions of prepared rhizome of rehmannia, 25 to 27 portions of radix paeonia alba, 15 to 17 portions of red paeonia, 5 to 7 portions of peach kernel, 5 to 7 portions of safflower, 25 to 27 portions of white atractylodes rhizome, 25 to 27 portions of tuckahoe, 11 to 13 portions of liquorice, 6 to 7 portions of ginseng and 9 to 11 portions of cordyceps sinensis.

Description

technical field [0001] The invention relates to a medicine for treating ischemic cerebral apoplexy, in particular to a medicine for treating ischemic cerebral apoplexy made from Chinese herbal medicines. Background technique [0002] Ischemic stroke is a type of acute cerebrovascular disease, also known as ischemic cerebrovascular disease, including transient ischemic attack, cerebral thrombosis, cerebral embolism and lacunar infarction, which is a common disease that seriously endangers human health. disease, frequently-occurring disease. According to statistics, the prevalence rate of cerebral apoplexy in the world is 5-6‰, and there is an increasing trend year by year. Stroke has the characteristics of high morbidity, high mortality, high disability rate, high recurrence rate and many complications. It is one of the three major diseases that currently cause human death (the other two major diseases are malignant tumors and coronary heart disease) . At present, the comp...

AI Technical Summary

Problems solved by technology

Although these treatment measures can achieve relatively good results, they can only be aimed at the acute attack stage of cerebral apoplexy, and only control and alleviate the deterioration of the disease. The effect on the recovery of the disease and the removal of sequelae is not ideal.

Although there are other treatment methods such as thrombosis and surgery, the risks are relatively high, and the medicines are affected by the time of onset, the age and physical condition of the patient, and are not practical.